About Ming Wai Lau Centre for Reparative Medicine
Ming Wai Lau Centre for Reparative Medicine is established to further accelerate research in stem cell biology, biomedical engineering, biotechnology, and regenerative medicine. With strong focus on technologies, a hub is being developed in Hong Kong to provide support and encouragement for increased research and innovation opportunities and further to strengthen the scientific interactions between Hong Kong and Karolinska Institutet.
Ming Wai Lau Centre for Reparative Medicine (MWLC) is the result of a donation by Hong Kong-based businessman Ming Wai Lau to Karolinska Institutet in early 2015. MWLC consists of two units, one in Stockholm and one in Hong Kong. The focus of the Hong Kong unit, which is established at the Hong Kong Science Park, is to establish a technology hub exploring novel technologies, including genome editing, reprogramming, single cell transcriptomics, biomedical engineering, and 3D tissue imaging technologies.
Three group leaders, at the Assistant Professor level, have been recruited to the Hong Kong unit. These are Sijie Chen, Linxian Li and Zongli Zheng. They will start their employments in February 2017.
The Stockholm unit encompasses a career support program for the most promising junior group leaders at KI in the broad subject of reparative medicine and who are pursuing outstanding research in subjects related to the field. The first six Lau Fellows were appointed in September 2016.
Finally, MWLC will establish a vibrant course program with research courses, workshops, and seminars at both the Stockholm and Hong Kong nodes, to further enhance interactions between the Karolinska Institutet and Hong Kong, and to create a vivid platform for synergistic collaborations.
The governing body of the MWLC is a steering group consisting of at least five and maximum eight members (see below).
The management team consists of the following five members:
|Phone:||+46-8-524 874 77|
|Phone:||+46-8-524 863 73|
|Phone:||+852 2624 3804|
|Phone:||+852 2624 3807|
Agneta Wallin Levinovitz
The steering group members are selected by the Vice Chancellor of Karolinska Institutet and they are:
Maria Masucci is Deputy Vice-Chancellor for International Affairs at Karolinska Institutet and Professor of Virology at Department of Cell and Molecular Biology.
She earned her MD with a specialisation in Oncology at the University of Ferrara Medical School in Italy.
Shortly thereafter, Professor Masucci came to KI, where she earned her doctorate in Tumour Biology and has been studying and working ever since.
Anders Gustafsson is Dean of Research at Karolinska Institutet and Professor of Periodontology at the Department of Dental Medicine and Dean of Research. He earned his dental and doctoral degrees at Karolinska Institutet, and was appointed professor in 2005 when he also became head of the unit for Periodontology and Dental Hygiene.
As Dean of Research, Anders Gustafsson is chair of Karolinska Institutet's Board of Research.
Marie Tell is Deputy University Director at Karolinska Institutet since 2007 and the University Director's representative.
From 1998 – 2001 she was Chief administrator at the Department of Molecular Medicine, Karolinska Institutet and between 2001 and 2007 Director of Administrative Development at the University Administration.
Marie Tell represents the host institution in the MWLC Steering group and is also the Administrative Director of MWLC.
Ming Wai Lau
Mr. Ming Wai Lau is the Chairman of Chinese Estates Holdings Ltd and Vice Chairman of the Bauhinia Foundation Research Centre. He holds a Master of Laws and a PhD from the London School of Economics and King’s College London
In 2015 he donated USD 50 million, equivalent to SEK 400 million, one of the largest private donations ever received by Karolinska Institutet.
Professor Paul Tam, is a surgeon, scientist, educator and university leader. He has been Chair of Paediatric Surgery at The University of Hong Kong since 1996 and Li Shu-Pui Professor in Surgery since 2013.
Professor Tam graduated from the University of Hong Kong. He has special interests in minimal invasive surgery, genetics and regenerative medicine of birth defects such as Hirschsprung’s disease. He has published over 369 articles in internationally refereed journals, serves on many international professional associations and on editorial boards of several international journals.
Wai-Yee Chan is Professor of Biomedical Sciences and Director of School of Biomedical Sciences, Faculty of Medicine, the Chinese University of Hong Kong since 2009. He obtained his Ph.D. from the University of Florida, USA. His expertise is in developmental genomics and epigenomics, and molecular genetics of human endocrine disorders. He serves as Editor/Associate Editor of several international scientific journals and in study sections of a number of research funding agencies including the US NIH, the Wellcome Trust and Health Research Board of UK, etc. He has edited 5 books, and published over 190 scientific articles.
The Scientific Director of MWLC, Dr Ola Hermanson is an adjunct member.
We are currently looking for:
Two Postdoctoral Researchers in Functional Genomics to join assistant professor Zongli Zheng. Deadline for application is 18 May 2017.
Two research assistants in experimental life science, material science, bioengineering/biomedical engineering or chemistry to join assistant professor Sijie Chen at the earliest convenience.
Agneta Wallin Levinovitz